Matches in Nanopublications for { ?s ?p "[Kinase domain mutations of BCR-ABL frequently precede imatinib-based therapy and give rise to relapse in patients with de novo Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- assertion description "[Kinase domain mutations of BCR-ABL frequently precede imatinib-based therapy and give rise to relapse in patients with de novo Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Kinase domain mutations of BCR-ABL frequently precede imatinib-based therapy and give rise to relapse in patients with de novo Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP373332.RAScl6mAOg0tomTLOjXgZKnTIGAXPiLUx0SRKcmlJfzH0130_assertion description "[Kinase domain mutations of BCR-ABL frequently precede imatinib-based therapy and give rise to relapse in patients with de novo Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP373332.RAScl6mAOg0tomTLOjXgZKnTIGAXPiLUx0SRKcmlJfzH0130_provenance.
- NP219615.RASxDKBzzZX60njX7AcgK3SUEiGNeEVtzU_wJo-WSba8w130_assertion description "[Kinase domain mutations of BCR-ABL frequently precede imatinib-based therapy and give rise to relapse in patients with de novo Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP219615.RASxDKBzzZX60njX7AcgK3SUEiGNeEVtzU_wJo-WSba8w130_provenance.
- NP602484.RAta4GFR76K5WVPc54eSr4Ml6f8MiEo-cilI9j3gLJd80130_assertion description "[Kinase domain mutations of BCR-ABL frequently precede imatinib-based therapy and give rise to relapse in patients with de novo Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP602484.RAta4GFR76K5WVPc54eSr4Ml6f8MiEo-cilI9j3gLJd80130_provenance.
- NP602485.RA-MpmIEG1_TdvrcX8xVBcLvCaMAeT_1IbJAmHWKJwRwA130_assertion description "[Kinase domain mutations of BCR-ABL frequently precede imatinib-based therapy and give rise to relapse in patients with de novo Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP602485.RA-MpmIEG1_TdvrcX8xVBcLvCaMAeT_1IbJAmHWKJwRwA130_provenance.